# Buerger disease

Condition · id `cardio:buerger-disease` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Thromboangiitis obliterans; Buerger's disease; TAO

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

Buerger disease, also called thromboangiitis obliterans (TAO), is an inflammatory disease that most often affects small and medium-sized arteries or veins in the extremities (the arms and legs), where clots block the vessels. MeSH says it is not caused by atherosclerosis and is highly associated with tobacco smoking, and that it can lead to ischemia (poor blood supply) in the digits and limbs and to ulcers. A 2025 review says the precise cause remains unclear, that surgical and endovascular approaches are largely ineffective because of the distal distribution of the disease and poor collateral circulation, and that current therapies mainly relieve symptoms.

## Technical summary

MeSH Thromboangiitis Obliterans (D013919, exact), whose broader descriptors are Vasculitis and Arterial Occlusive Diseases. MeSH and the review both describe it as non-atherosclerotic, while the atlas page for peripheral artery disease is filed under atherosclerosis, so this record has no subtype\_of parent and links to peripheral artery disease with related\_to; the atlas has no vasculitis page. The record rests on the MeSH scope note and a 2025 open-access review (PMC12420300, CC BY 4.0). The smoking link is MeSH wording (highly associated) and is not stated here as a cause or as a risk figure. The review's mechanism and experimental-therapy sections are not repeated. The evidence recorded is descriptive and comes from a vocabulary entry and one review, with no study data.

## Claims, with the population each applies to

## Context: People with thromboangiitis obliterans (MeSH scope note and a narrative review)

Recipient: Recipient not specified; Population: People with thromboangiitis obliterans, a non-atherosclerotic inflammatory disease of small and medium-sized arteries and veins in the extremities, as the MeSH scope note and a 2025 review describe it.; Care setting: Not stated for the MeSH note. The review discusses surgical and endovascular approaches and medical therapies in general terms.; Geography: Not stated. The sources do not name a country.; Life stage: Not stated. This record makes no statement about pregnancy, newborns or children.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (a description of a condition).

### MeSH describes thromboangiitis obliterans as a non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities, with occlusive thrombosis and fibrosis in the vessel wall leading to digital and limb ischemia and ulcers, and says it is highly associated with tobacco smoking. A 2025 review (Frontiers in Immunology) describes a non-atherosclerotic, inflammatory vasculopathy with thrombotic occlusion of small and medium-sized vessels leading to tissue ischemia and gangrene. It says the precise pathogenesis remains unclear, that the distal distribution and poor collateral circulation render surgical and endovascular approaches largely ineffective, and that current therapies primarily alleviate symptoms.

- Category: Description
- Evidence stage: Evidence synthesis
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: People with thromboangiitis obliterans, a non-atherosclerotic inflammatory disease of small and medium-sized arteries and veins in the extremities, as the MeSH scope note and a 2025 review describe it.; Care setting: Not stated for the MeSH note. The review discusses surgical and endovascular approaches and medical therapies in general terms.; Geography: Not stated. The sources do not name a country.; Life stage: Not stated. This record makes no statement about pregnancy, newborns or children.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (a description of a condition).
- Limitations: A vocabulary scope note and one review article, with no study data. The review's statements about its mechanism, autoimmune features and experimental therapies are not repeated. Highly associated is MeSH wording; no rate or size of association is given, and it is not a statement of cause.
- Last checked: 2026-11-18
- Sources:
  1. Supports: MeSH scope note for descriptor D013919 (Thromboangiitis Obliterans) (Dataset, edition MeSH linked-data record of the preferred concept M0021426 of descriptor D013919, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0021426>
     Locator: scopeNote.@value, sentence 1. Retrieved 2026-11-18T17:19:11Z. Source state: Current. Version fingerprint: c067c0e11dcb6cfc724f44f2c8ee5ae40e768b15a8c6fc875f6e0d4b6e801c0b.
     How it applies: MeSH: a non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities.
  2. Supports: MeSH scope note for descriptor D013919 (Thromboangiitis Obliterans) (Dataset, edition MeSH linked-data record of the preferred concept M0021426 of descriptor D013919, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0021426>
     Locator: scopeNote.@value, sentence 2. Retrieved 2026-11-18T17:19:11Z. Source state: Current. Version fingerprint: c067c0e11dcb6cfc724f44f2c8ee5ae40e768b15a8c6fc875f6e0d4b6e801c0b.
     How it applies: MeSH: occlusive thrombosis and fibrosis in the vessel wall lead to digital and limb ischemia and ulcers.
  3. Supports: MeSH scope note for descriptor D013919 (Thromboangiitis Obliterans) (Dataset, edition MeSH linked-data record of the preferred concept M0021426 of descriptor D013919, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0021426>
     Locator: scopeNote.@value, sentence 3. Retrieved 2026-11-18T17:19:11Z. Source state: Current. Version fingerprint: c067c0e11dcb6cfc724f44f2c8ee5ae40e768b15a8c6fc875f6e0d4b6e801c0b.
     How it applies: MeSH: highly associated with tobacco smoking.
  4. Supports: Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC12420300/>
     Locator: Abstract, sentence 1. Retrieved 2026-11-18T17:27:12Z. Source state: Current. Version fingerprint: 0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b.
     How it applies: The review describes a non-atherosclerotic, inflammatory vasculopathy with thrombotic occlusion of small and medium-sized vessels, leading to tissue ischemia and gangrene.
  5. Supports: Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC12420300/>
     Locator: Introduction, para 1, sentence 3. Retrieved 2026-11-18T17:27:12Z. Source state: Current. Version fingerprint: 0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b.
     How it applies: The review says surgical and endovascular approaches are largely ineffective because of the distal distribution and poor collateral circulation.
  6. Background: Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC12420300/>
     Locator: Introduction, para 1, sentence 4 (first part). Retrieved 2026-11-18T17:27:12Z. Source state: Current. Version fingerprint: 0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b.
     How it applies: The review says the precise pathogenesis remains unclear.
  7. Background: Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC12420300/>
     Locator: Abstract, sentence 4. Retrieved 2026-11-18T17:27:12Z. Source state: Current. Version fingerprint: 0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b.
     How it applies: The review says current therapies mainly relieve symptoms.

## Connected pages

- Filed under this front: Prevention and lifestyle (`cardio:front-prevention-and-lifestyle`)
- Both can block arteries in the limbs; MeSH describes Buerger disease as non-atherosclerotic: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- MeSH says thromboangiitis obliterans is highly associated with tobacco smoking: Tobacco smoking (`core:tobacco-smoking`)
- Related to: Vasculitis (`cardio:vasculitis`)

## Provenance

Content hash: 90cd830b7d2d1b3fb0f2bcf7438769cdf373781f999154c201aaf2851260e6d1
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
